Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$561M |
| 2 |
Citizens Financial Group
CFG
|
+$465M |
| 3 |
NRF
NorthStar Realty Finance Corp.
NRF
|
+$462M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$439M |
| 5 |
WEC Energy
WEC
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LO
LORILLARD INC COM STK
LO
|
+$1.33B |
| 2 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$1B |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$968M |
| 4 |
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
|
+$740M |
| 5 |
Wells Fargo
WFC
|
+$512M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.24% |
| 2 | Financials | 14.23% |
| 3 | Technology | 13.63% |
| 4 | Industrials | 10.55% |
| 5 | Consumer Discretionary | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SDRL
1701
DELISTED
Seadrill Limited Common Stock
SDRL
| $77.4M | 0.01% |
27,971
+1,558
| +6% | +$5.02M |
|
1702
Scansource
SCSC
$1.2B
| $77.2M | 0.01% |
2,027,969
+53,400
| +3% | +$2.12M |
|
|
GES
1703
DELISTED
Guess Inc
GES
| $77M | 0.01% |
4,016,219
+112,237
| +3% | +$2.11M |
|
|
JBTM
1704
JBT Marel
JBTM
$6.9B
| $76.9M | 0.01% |
2,046,921
+173,162
| +9% | +$6.39M |
|
1705
First Financial Bancorp
FFBC
$3.62B
| $76.9M | 0.01% |
4,284,028
+126,337
| +3% | +$2.22M |
|
1706
Clearwater Paper
CLW
$369M
| $76.8M | 0.01% |
1,340,200
+22,069
| +2% | +$1.36M |
|
|
EMBJ
1707
Embraer S.A. ADS
EMBJ
$12.5B
| $76.6M | 0.01% |
2,530,451
-16,133
| -0.6% | -$498K |
|
1708
Virtus Investment Partners
VRTS
$1.11B
| $76.6M | 0.01% |
579,468
+9,945
| +2% | +$1.3M |
|
1709
Sarepta Therapeutics
SRPT
$1.73B
| $76.1M | 0.01% |
2,502,173
+78,763
| +3% | +$1.61M |
|
|
CUB
1710
DELISTED
Cubic Corporation
CUB
| $76.1M | 0.01% |
1,599,656
+98,974
| +7% | +$4.86M |
|
1711
AAR Corp
AIR
$5.96B
| $76.1M | 0.01% |
2,387,144
-220,262
| -8% | -$6.72M |
|
|
APOL
1712
DELISTED
Apollo Education Group Inc Class A
APOL
| $76M | 0.01% |
5,898,972
+64,759
| +1% | +$1.09M |
|
|
BRLI
1713
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| $76M | 0.01% |
1,841,215
+37,161
| +2% | +$1.33M |
|
|
NXGN
1714
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $75.9M | 0.01% |
4,582,537
+1,056,108
| +30% | +$17M |
|
|
ARNA
1715
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $75.6M | 0.01% |
1,629,670
+51,680
| +3% | +$2.24M |
|
1716
Methode Electronics
MEI
$536M
| $75.6M | 0.01% |
2,754,485
+696,570
| +34% | +$31.2M |
|
1717
Cameco
CCJ
$40.5B
| $75.6M | 0.01% |
5,291,032
+427,219
| +9% | +$6.75M |
|
|
CMO
1718
DELISTED
Capstead Mortgage Corp.
CMO
| $75.4M | 0.01% |
6,791,032
+221,970
| +3% | +$2.62M |
|
|
TUMI
1719
DELISTED
TUMI HLDGS INC COM
TUMI
| $75.4M | 0.01% |
3,672,268
+224,977
| +7% | +$4.91M |
|
|
NAV
1720
DELISTED
Navistar International
NAV
| $74.8M | 0.01% |
3,307,189
+51,934
| +2% | +$1.42M |
|
|
JUNO
1721
DELISTED
Juno Therapeutics, Inc.
JUNO
| $74.5M | 0.01% |
1,397,829
+44,697
| +3% | +$2.37M |
|
1722
St. Joe Company
JOE
$3.69B
| $74.3M | 0.01% |
4,785,342
+148,979
| +3% | +$2.5M |
|
1723
Tidewater
TDW
$4.19B
| $74.1M | 0.01% |
101,090
+4,349
| +4% | +$3.54M |
|
1724
Coherent
COHR
$63.3B
| $74M | 0.01% |
3,900,397
+34,243
| +0.9% | +$638K |
|
1725
Encore Capital Group
ECPG
$2.05B
| $73.8M | 0.01% |
1,727,662
+27,867
| +2% | +$1.14M |
|
Similar funds
Vanguard Group's Q2 2015 Portfolio in Review
As of Q2 2015, Vanguard Group held 4,259 positions worth $1.48T, up 0.33% from $1.47T the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Trading was light in Q2 2015: portfolio turnover was 4%. Vanguard Group opened 105 new positions and exited 67, leaving the 4,259-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Financials and Technology.
- Vanguard Group's largest Q2 2015 buy was Uniti Group: 7,979,038 shares worth $197M.
- Vanguard Group added most to AbbVie in Q2 2015, an estimated $561M increase.
- Vanguard Group's biggest Q2 2015 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $968M.
- Vanguard Group fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $1.33B.
- Vanguard Group's ten largest holdings make up 13% of its $1.48T portfolio in Q2 2015.
- Vanguard Group opened 105 new positions and closed 67 in Q2 2015.
- Vanguard Group's portfolio value rose 0.33% quarter-over-quarter to $1.48T.
Based on Vanguard Group's 13F filing for Q2 2015, filed 13 Aug 2015.